Research into areas like cancer could become collateral damage of a broader anti-mRNA push, according to a new study.

The messenger RNA (mRNA) market is undergoing significant expansion, driven by its versatile approach in treating and ...

As RNA therapeutics evolve far beyond their vaccine origins, a new generation of scientists and manufacturers is rethinking how to produce these complex medicines safely, efficiently, and at scale.

An mRNA cancer vaccine carries its own immune booster and lights up when it starts working, showing treatment success in mice within hours. (Nanowerk Spotlight) Messenger RNA (mRNA) vaccines ...

Washington — U.S. Food and Drug Administration Commissioner Marty Makary on Monday defended his agency's position and record on mRNA vaccines, days after it changed course and agreed to review a ...

Researchers are edging closer to something long imagined but never quite within reach: a single vaccine platform that could be adapted to fight many kinds of cancer. Early experiments in animals and ...

PARIS (Reuters) - France's top health body will on Friday say that recipients of a first dose of AstraZeneca's traditional COVID-19 vaccine who are under 55 should get a second shot with a new-style ...

The U.S. Food and Drug Administration will review a messenger RNA (mRNA) flu vaccine for approval, according to its maker, Moderna. The decision is a dramatic U-turn for the agency, which, only about ...